MétaCan
Menu
Retour à la cohorte
Enregistrement W210972811 · doi:10.1111/irv.12298

Leader in Global Influenza Prevention and Control Retires after 37 Years

2014· article· en· W210972811 sur OpenAlexaboutno aff

Notice bibliographique

RevueInfluenza and Other Respiratory Viruses · 2014
Typearticle
Langueen
DomaineMedicine
ThématiqueInfluenza Virus Research Studies
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésCharterPandemicPolitical scienceMedicineVirologyCoronavirus disease 2019 (COVID-19)DiseaseLawInfectious disease (medical specialty)Pathology

Résumé

récupéré en direct d'OpenAlex

At the end of November, ISIRV cofounder and Influenza and Other Respiratory Viruses editorial board member Dr Nancy Cox retired from her position as Director of the U.S. Centers for Disease Control and Prevention's Influenza Division. She left this position after 37 years of distinguished federal service at CDC, where she also served as the Director of one of five World Health Organization Collaborating Centers for the Surveillance, Epidemiology and Control of Influenza. Dr Cox started working on influenza at CDC in 1976. After almost four decades and 278 publications, she has transformed the surveillance and science of influenza viruses and vaccines. Her scientific work has been critical, given the tremendous global burden of human seasonal influenza – 1 billion cases, 3–5 million severe illnesses, and 300–500 000 deaths each year. In addition, avian or swine influenza viruses can adapt to human-to-human transmission, leading to global and devastating pandemics with disruption in commerce and tragic numbers of illnesses and deaths. The breadth and depth of influenza's impact is vast, underscoring Dr Cox's vital contribution from her science and service. Dr Cox was a key founding member of ISIRV. She and the other cofounders formed the organization in 2006 and signed its original charter, establishing the core principles of scientific integrity and independence that remain the hallmarks of ISIRV policy today. ISIRV was established in part to be the home for the ‘Options for the Control of Influenza’ series of meetings. ‘Options VI’ held in Toronto, Canada in 2007 was the first meeting held under the ISIRV umbrella and was organized by Dr Cox and her CDC colleagues. Dr Cox is an Iowa native (born in Emmetsburg) and attended Iowa State University where she received a BS in Bacteriology in 1970. She is a life member of the ISU alumni association. In addition to her Iowa State degree, she has a doctorate in virology from the University of Cambridge and was a post-doctoral fellow at both the University of Maryland, Baltimore County and at the Centers for Disease Control and Prevention. Dr Cox has been recognized by virologists, public health officials, leaders in state and federal governments, international leaders, academics, and others. She is the recipient of multiple CDC recognition awards, including 4 CDC Shepard Awards for excellence in scientific publications, the Lancet ‘Paper of the Year,’ Time Magazine's ‘The Time 100: People Who Shape Our World,’ Service to America Award, CDC's Lifetime Achievement Award and the USG-wide award for Federal Employee of the Year. She has been a reviewer of numerous articles, the chair of many scientific panels and symposia and has served on various scientific committees for international conferences and global influenza policy development workgroups. During her 37 years at CDC, Dr Cox has served as mentor, educator, supervisor, and supporter to hundreds of individuals: undergraduate, medical and PhD students, post-doctoral fellows, laboratory and epidemiology staff members, journalists, and visiting researchers. As Director of the WHO Collaborating Center for the Surveillance, Epidemiology and Control of Influenza at CDC, Dr Cox has worked closely with public health laboratory officials from Russia, Vietnam, and China, leading to transforming their capabilities in influenza virology and surveillance. Her oversight of influenza laboratories at CDC has set the standards for measuring immune response in infected and vaccinated people and also has led CDC to be the global reference center for antiviral resistance and for measuring transmission of influenza viruses in animal models. Her leadership at WHO has also led to significant changes in the methods, reporting, interpretation, and policy development for selecting candidate vaccine viruses for use in annual vaccine production. Through Dr Cox's scientific rigor, knowledge and foresight, she leaves a legacy of improved capacity for the study of influenza virus across the globe.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,006
score de la tête « metaresearch » (Gemma)0,011
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: Sans objet
GenreSignal candidat: Éditorial · Signal consensuel: Éditorial
Score de désaccord entre enseignants0,062
Score d'incertitude au seuil0,208

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0060,011
Méta-épidémiologie (sens strict)0,0020,001
Méta-épidémiologie (sens large)0,0010,001
Bibliométrie0,0020,001
Études des sciences et des technologies0,0020,001
Communication savante0,0070,004
Science ouverte0,0010,003
Intégrité de la recherche0,0060,013
Charge utile insuffisante (le modèle a refusé de juger)0,0620,056

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,131
Tête enseignante GPT0,418
Écart entre enseignants0,288 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeSans objet
Domainenon disponible
GenreÉditorial

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2014
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueInfluenza and Other Respiratory VirusesMême sujetInfluenza Virus Research StudiesTravaux en français237 207